Mumbai: On World Cancer Day, the Illuminate Oncology Townhall 2.0 was held at Jio World Convention Centre, bringing together experts from India and around the world to discuss advancements in cancer treatment, diagnosis, and immunotherapy.
The event was organized by Dr. Sewanti Limaye from Sir H.N. Reliance Foundation Hospital.
Discussions focused on CAR-T cell therapy, new immunotherapies, and emerging cancer vaccines. Experts emphasized the importance of multidisciplinary cancer care, early screening, and patient advocacy.
Dr. Tarang Gianchandani, Group CEO, Reliance Healthcare Services and CEO, Sir H.N. Reliance Foundation Hospital, said, “Further to the WHO theme of ‘United by Unique,’ we hosted Illuminate to bring the unique expertise and knowledge of top oncology experts from across the globe to India. The discussions led to a very productive exchange of ideas with experts sharing enlightening insights on multidisciplinary treatments and precision oncology.”
Dr. Vijay V. Haribhakti, Chair of Oncosciences, Sir H.N. Reliance Foundation Hospital, added, “With cancer cases projected to rise significantly, it is imperative to strengthen our approach through knowledge exchange and collaboration. Illuminate 2.0 provided a space where leading experts could discuss breakthroughs in cancer treatment, such as strategic preventative approaches like tobacco avoidance, screening, and surgical innovations. These conversations will play a key role in shaping the future of oncology care in India and beyond.”
Dr. Sewanti Limaye, the event convener, emphasized the importance of multidisciplinary treatment and public participation in screening efforts, saying, “Through this Oncology Townhall, we wish to bring multidisciplinary cancer care to the forefront and present it as a mandatory requirement in planning the care for a cancer patient today. We also wish to appeal to the masses to own cancer screening efforts and help bring about a revolution in cancer prevention.”
Leading oncologists from around the world participated, including Nobel Laureate Dr. James Allison and specialists from MD Anderson Cancer Center, Mount Sinai, Tata Memorial Hospital, and the Chinese University of Hong Kong. Experts discussed advancements in cell lysate cancer vaccines, peptide cancer vaccines, and CAR-T cell therapy.
The town hall provided a platform for experts to exchange ideas on improving cancer care and making new treatments more accessible.
